Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidelines For Preventing Sudden Cardiac Death Could Impact ICD Sales

This article was originally published in The Gray Sheet

Executive Summary

For the first time, physicians have access to comprehensive, widely endorsed guidelines for the prevention of sudden cardiac death - including clearer recommendations than ever before about when to treat various types of patients with implantable cardioverter defibrillators
Advertisement

Related Content

Study Questions Benefit Of ICDs In Dialysis Patients, Cites Need For Research
Medtronic To Cardiologists: Get With The Guidelines On ICD Use
Medtronic To Cardiologists: Get With The Guidelines On ICD Use
Study Questions Benefit Of ICDs In Dialysis Patients, Cites Need For Research
New ICD Registry Goes Above And Beyond Medicare Mandate
New ICD Registry Goes Above And Beyond Medicare Mandate
Advertisement
UsernamePublicRestriction

Register

MT023946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel